Literature DB >> 31528138

Reverse Takotsubo Cardiomyopathy in a Patient With Prior Apical Takotsubo Cardiomyopathy: Challenging the Beta Receptor Gradient Theory.

Ahmed Rashed1, Mohamed Shokr1, Ahmed Subahi2, Fayez Siddiqui1, Aziz Alkatib1, Luis Afonso1.   

Abstract

Background: Classic Takotsubo cardiomyopathy has been described as transient apical dyskinesia following major stress that is believed to be related to catecholamine surges. Atypical variants have been described, including the rarer reverse Takotsubo cardiomyopathy. Discrepant gradients of the beta-2 adrenoceptors are thought to determine the different anatomic variants. Case Report: A 43-year-old female presented with chest pain and a mild troponin elevation. Echocardiography and coronary angiography were consistent with stress-induced apical Takotsubo cardiomyopathy. Eight months later, the patient was admitted with a similar presentation; however, workup revealed stress-induced reverse Takotsubo cardiomyopathy.
Conclusion: Recurrent Takotsubo cardiomyopathy involving different anatomic regions of the left ventricle is a rare phenomenon yet appears to be similar to typical Takotsubo cardiomyopathy in presentation and hospital course. Chronic therapy with beta blockers and angiotensin-converting enzyme inhibitors did not prevent a recurrence in this patient, suggesting that optimum treatment needs to be determined. Takotsubo cardiomyopathy affecting different myocardial segments may recur in the same patient, implying that the adrenoceptor distribution theory needs further refinement.

Entities:  

Keywords:  Cardiomyopathy; Takotsubo cardiomyopathy; heart failure; receptors–adrenergic

Year:  2019        PMID: 31528138      PMCID: PMC6735595          DOI: 10.31486/toj.18.0027

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  1 in total

1.  Takotsubo Syndrome: A Recurrent Disease?

Authors:  Fábio Fernandes; Marcelo Westmoreland Montera
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.